Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jennifer Kwan-morley (NPI 1285799379)

Field	Value
Entity Type	Individual
Organization	Jennifer Kwan-morley
Address	266 Lancaster Ave
City	Malvern
State	PA
ZIP	19355
Taxonomy	Rheumatology Physician
NPI Enumerated	December 27, 2006

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

This provider’s Medicare activity is concentrated in infused and injected biologic therapies consistent with a rheumatology infusion service: the top revenue-driving codes are J0129 (abatacept), J0897 (denosumab) and J9312 (rituximab), and these agents plus related administration codes (96413, 96365, 96415) dominate the billing mix. The lifetime Medicare revenue on file is $2.5M, and the predominance of high-cost injectable biologics in the top codes indicates the practice operates an on-site infusion/administration workflow rather than being limited to only office-based evaluation and management visits.

Revenue concentration is high: the precomputed top-3 Medicare codes account for 56.9% of this provider’s total Medicare revenue, with J0129 reporting $527.9K (21.0% of Medicare revenue), J0897 reporting $502.2K (20.0%), and J9312 reporting $399K (15.9%). This level of concentration means a majority of Medicare dollars for this provider are tied to a small set of biologic agents rather than dispersed across many E/M codes.

The payer mix is effectively single-payer Medicare: total Medicare revenue on file is $2.5M while there is no Medicaid billing on file, so the practice has no reported Medicaid revenue to diversify overall payer exposure. Absence of Medicaid activity suggests competitive and reimbursement dynamics should be evaluated primarily against Medicare patterns and peer behavior in the commercial/Medicare infusion markets rather than state Medicaid trends.

Competitive standing across codes is mixed: J0897 ranks #115 of 10057 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code), indicating unusually high denosumab administration relative to national peers, while J9312 ranks #34 of 317 providers nationally (90th percentile; typical, unremarkable volume) showing strong but not singular participation in rituximab use. By contrast J0129 ranks #226 of 1221 providers nationally (81th percentile; typical, unremarkable volume), so abatacept use is solid but not exceptional versus national peers.

Office visit E/M activity is notable alongside infusion work: 99214 shows 1.4K claims, $98 avg paid/claim, $138.8K revenue (5.5% of Medicare revenue) and ranks #4310 of 479517 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). This combination of high-volume mid-complexity E/M visits plus heavy infusion billing suggests the provider manages ongoing chronic therapy regimens with substantial follow-up care.

Operational/clinical support services are meaningfully utilized: infusion and administration-related codes such as 96413 (294 claims, $31.8K), 96365 (380 claims, $20.5K), 96415 (305 claims, $7K; ranks notably above typical at the 95th percentile) and 96372 (621 claims, $7.5K; ranks notably above typical at the 98th percentile) indicate frequent initial infusions, extended infusions, and multiple medication administrations per session. These patterns are consistent with a practice set up to deliver and bill for repeated IV and subcutaneous therapies, including add-on monitoring time and infusion continuation.

Tenure and specialty profile reinforce an established local footprint: the NPI was enumerated on 2006-12-27 (~20 years ago) and the provider taxonomy is Rheumatology Physician in Malvern, PA. The longevity and specialty align with the observed biologic and infusion-centric code mix and suggest a mature outpatient rheumatology practice focused on disease-modifying biologic management and follow-up care.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	15,530	$30	$527.9K
J0897	Injection, denosumab, 1 mg	27,900	$20	$502.2K
J9312	Injection, rituximab, 10 mg	6,650	$60	$399K
J1602	Injection, golimumab, 1 mg, for intravenous use	24,700	$10	$271.7K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	49,200	$1	$196.8K
J3262	Injection, tocilizumab, 1 mg	38,100	$10	$190.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,280	$30	$163.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,420	$100	$138.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	290	$110	$31.8K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	380	$50	$20.5K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Jennifer Kwan-morley — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	12	60	7,900	$30	$353.8K
J3262	20	30	45,000	$1	$268K
J0717	25	70	38,610	$1	$223.7K
J9312	1	10	2,330	$60	$192K
J1602	11	60	11,780	$10	$181.6K
J1745	16	80	3,630	$30	$115.4K
J0897	4	530	2,460	$20	$89.6K
J7326	90	110	30	$400	$21K
96413	69	300	140	$100	$19.8K
99214	70	23,230	100	$80	$14.5K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jennifer Kwan-morley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Premier Orthopaedic And Sports Medicine Associates, Ltd	PA	Orthopaedic Surgery Physician	$0	$7.1M
Michael Shriver	OH	Diagnostic Radiology Physician	$1.1M	$0
Stephanie Morris	PA	Rheumatology Physician	$742.6K	$0
Stephen Pomeranz	OH	Diagnostic Radiology Physician	$642.3K	$0
Cheston Simmons	PA	Orthopaedic Surgery Physician	$570.3K	$0
Nikos Pavlides	PA	Orthopaedic Surgery Physician	$448.3K	$0
Larry Chou	PA	Physical Medicine & Rehabilitation Physician	$444.8K	$0
Andrew Old	PA	Orthopaedic Surgery Physician	$420.7K	$0
Kevin Walsh	PA	Sports Medicine (Family Medicine) Physician	$336.4K	$0
Todd Michener	PA	Orthopaedic Surgery Physician	$307.6K	$0

Nearby Providers

Other providers in the same ZIP code as Jennifer Kwan-morley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Malvern Institute For Psychiatric And Alcoholic Studies, Inc.	PA	Special Hospital	$0	$91.7M
Cardionet, LLC	PA	Physiological Laboratory	$11M	$63.2M
Childrens Surgery Center Of Malvern, LLC	PA	Ambulatory Surgical Clinic/Center	$0	$11.3M
Ramsis Holdings, Hands From The Heart Home Healthcare Services	PA	Home Health Agency	$0	$8.3M
Danielle Young	PA	Family Nurse Practitioner	$3.7M	$0
Coram Alternate Site Services Inc	PA	Home Infusion Therapy Pharmacy	$54.7K	$2.6M
Caitlin Trainor	PA	Family Nurse Practitioner	$1.3M	$0
Main Line PA Endoscopy Asc LP	PA	Ambulatory Surgical Clinic/Center	$1.1M	$0
Jeffrey Rihn	PA	Orthopaedic Surgery Physician	$472.1K	$0
Danielle Boyle	PA	Family Nurse Practitioner	$411.3K	$0

Jennifer Kwan-morley — Billing Profile & Reimbursement Data

Sign up for Jennifer Kwan-morley — Billing Profile & Reimbursement Data policy alerts

Jennifer Kwan-morley — Billing Profile & Reimbursement Data

Sign up for Jennifer Kwan-morley — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References